Sections & Products

Main > ONCOLOGY (**)

ONCOLOGY (**)'s subsections

Ablation.

Active Pharma. Ingredients (APIs.)

Acute Radiation Syndrome ***

AntiBody

AntiSense DNA Therapeutics

Biblical Oncology.

BioMarker ***

Biopsy>Closure Device

Biopsy>Liquid (Diag.) ***

Biopsy>Liquid (Diag.>Companion) ***

Bladder Cancer ***

Bladder Cancer>mUC ***

Bladder Cancer>NMIBC

Bone Cancer>OsteoSarcoma ***

Bone Marrow Transplantation ***

Bone MET>from Solid Tumors ***

Bone MET>Pain ***

BPDCN>Treat.>Tagraxofusp ***

Brain Cancer ***

Brain Cancer>GBM ***

Brain Cancer>GBM>Recurrent (R) *

Brain Cancer>pLGG R/R

Brain Cancer>SEGA>TSC ***

Breast Cancer ***

Breast Cancer>Benign FibroAdenoma

Breast Cancer>BLBC

Breast Cancer>Companion Diagnostics

Breast Cancer>Early>High Risk>HER2-

Breast Cancer>ER+ ***

Breast Cancer>ER+>HER2- ***

Breast Cancer>ER+>HER2->Lymph Node+

Breast Cancer>ER+>MET>PM ***

Breast Cancer>ER->HER2->PR->

Breast Cancer>FGFR1 Amplified+ ***

Breast Cancer>HER2+ ***

Breast Cancer>HER2+>Adjuvant ***

Breast Cancer>HER2+>MET ***

Breast Cancer>HER2/neu+ ***

Breast Cancer>Hereditary ***

Breast Cancer>HR+>HER2+>MET>PM *

Breast Cancer>HR+>HER2->DIAG.

Breast Cancer>HR+>HER2->MET ***

Breast Cancer>HR+>HER2->MET>PIK3CA-

Breast Cancer>HR+>HER2->MET>PM *

Breast Cancer>HR+>HER2->Node(+)>

Breast Cancer>HR+>MET ***

Breast Cancer>HR+>PM ***

Breast Cancer>MET ***

Breast Cancer>MET Bone Dis ***

Breast Cancer>MET>HER2->gBRCA->*

Breast Cancer>PR+ ***

BTC>Advanced or MET>Treat.>

BTC>FGFR2+

Carcinoid Syndrome ***

Carcinoid Syndrome Diarrhea ***

Cell Isolation.

Cell Therapy ***

Cervical Cancer ***

Cervical Cancer>MET>R

ChemoTherapy (CT) ***

CholangioCarcinoma>MET>

CholangioCarcinoma>MET>FGFR2+>

Clinical Trial Patient Matching **

Colon Cancer ***

Colon Cancer>Dukes C (Stage III) *

Colon Cancer>Individual Treat.>

Colon Cancer>MET ***

Colon Cancer>MET>MSI-H *

Colon Cancer>MET>NRAS+ ***

Colon Cancer>MET>RAS/BRAF wild-type

Colon Cancer>Polyp Removal

Companion DIAG. Solid Tumors *

Diagnostics.

DoxoRubicin.HCl [PENDANT (P)]

Drug Delivery ***

Drug Development.

Drug Discovery ***

Endometrial Cancer

Esophageal>AdenoCarcinoma

Esophageal>Non Squamous>MET

Esophageal>Squamous>Advanced>MET>

Esophageal>Squamous>Advanced>R>

Exosomes ***

Eye Cancer>Uveal Melanoma ***

Gastric Cancer ***

Gastric Cancer>Adenocarcinoma ***

Gastric Cancer>Advanced or MET

Gastric Cancer>c-MET Amplified+ ***

Gastric Cancer>HER2-,CLDN18.2+>

Gastric Cancer>MET HER2+

Gastric Cancer>MET or R ***

Gastric Cancer>MET or R PD-L1+***

Gastric Cancer>MET>R>LA>U

GC/GEJ MET Adenocarcinoma>

GEJ Cancer MET or R PD-L1+ ***

Gene Delivery ***

Gene Mutation ***

Genomics.

GIST

GIST>PDGFRA Exon 18 Mutant>MET Or

Head & Neck>C.***

Head & Neck>C.>Locally Advanced>>

Head & Neck>C.>MET ***

Head & Neck>C.>R or> ***

Head & Neck>Squamous>C. ***

Head & Neck>Squamous>C.>MET Or R

HyperCalcemia ***

hyperVascular Tumors

IL. B. Prostate Cancer>RT>Rectal>

IL. M. CRC>Colonoscopy>AI GI>

ImmunoTherapy ***

Information Web-Site ***

Kidney Cancer>RCC ***

Kidney Cancer>RCC>MET ***

Kidney Cancer>RCC>Post Surgery>

Kidney Cancer>RCC>PostSurgery>R ***

Leukemia>Eosinophilic>Chronic ***

Leukemia>Hairy Cell Leukemia>R/R*>

Leukemia>Lymphoblastic>Acute ***

Leukemia>Lymphoblastic>Acute>MRD

Leukemia>Lymphoblastic>Acute>Ph+***

Leukemia>Lymphoblastic>Acute>Ph-R/R

Leukemia>Lymphoblastic>Acute>R/R***

Leukemia>Lymphocytic>Chronic ***

Leukemia>Lymphocytic>Chronic>HCT>

Leukemia>Lymphocytic>Chronic>MRD *

Leukemia>Lymphocytic>Chronic>R ***

Leukemia>Lymphocytic>Chronic>R/R>**

Leukemia>Mast Cell ***

Leukemia>Myeloid>Acute>1st CR

Leukemia>Myeloid>Acute>CD33+***

Leukemia>Myeloid>Acute>FLT3+ ***

Leukemia>Myeloid>Acute>IDH1+ R/R

Leukemia>Myeloid>Acute>IDH2+ R/R*

Leukemia>Myeloid>Acute>Newly Diag+>

Leukemia>Myeloid>Acute>R Free ***

Leukemia>Myeloid>Acute>R/R

Leukemia>Myeloid>Acute>t-AML or> *

Leukemia>Myeloid>Chronic ***

Leukemia>Myeloid>Chronic>CP

Leukemia>Myeloid>Chronic>CP Ph+

Leukemia>Myeloid>Chronic>Ph+ *

Leukemia>ProMyelocytic>Acute>R***

Liver Cancer ***

Lung>Cancer>Diagnostics ***

Lung>NSCLC>Early Stage PD-L1≥

Lung>NSCLC>EGFR Exon20 Insertion+>

Lung>NSCLC>EGFR T790M+>MET

Lung>NSCLC>EGFR+>MET>***

Lung>NSCLC>EndoBronchial *

Lung>NSCLC>MET+> ***

Lung>NSCLC>MET>ALK(+) or ROS1(+) *

Lung>NSCLC>MET>ALK+ ***

Lung>NSCLC>MET>Exon 14 Skipping

Lung>NSCLC>MET>HER2 Mutant>

Lung>NSCLC>MET>KRAS G12C+>

Lung>NSCLC>MET>METex14+

Lung>NSCLC>MET>or RECURRENT

Lung>NSCLC>MET>PD-L1+>> ***

Lung>NSCLC>MET>PD-L1>1%

Lung>NSCLC>MET>PD-L1>50%

Lung>NSCLC>MET>PD-L1>High+

Lung>NSCLC>MET>RET Fusion+

Lung>NSCLC>MET>ROS1(+)

Lung>NSCLC>MET>With BRAF V600E>***

Lung>NSCLC>Non-Squamous>1st Line

Lung>NSCLC>Non-Squamous>MET EGFR->+

Lung>NSCLC>Non-Squamous>MET or R***

Lung>NSCLC>Post Surgical Resection>

Lung>NSCLC>Resectable (tumors>4cm o

Lung>NSCLC>Squamous>MET>

Lung>NSCLC>Stage III>MET>PD-L1+>>

Lung>SCLC>ES SCLC

Lung>SCLC>MET

Lymphoma>HL>Classical> ***

Lymphoma>HL>Classical>auto-HSCT>R**

Lymphoma>HL>Classical>R/R ***

Lymphoma>HL>Classical>Stage 3/4>+

Lymphoma>NHL>Auto. Transplant.***

Lymphoma>NHL>B-Cell>DLBCL R/R***

Lymphoma>NHL>B-Cell>DLBCL***

Lymphoma>NHL>B-Cell>FL ***

Lymphoma>NHL>B-Cell>FL R ***

Lymphoma>NHL>B-Cell>FL R/R CD20+***

Lymphoma>NHL>B-Cell>FL R/R EZH2+

Lymphoma>NHL>B-Cell>FL R/R>***

Lymphoma>NHL>B-Cell>HGBL R/R

Lymphoma>NHL>B-Cell>Indolent>R***

Lymphoma>NHL>B-Cell>LBCL R/R

Lymphoma>NHL>B-Cell>MCL

Lymphoma>NHL>B-Cell>MCL R

Lymphoma>NHL>B-Cell>MCL R/R

Lymphoma>NHL>B-Cell>MZL R/R***

Lymphoma>NHL>B-Cell>PMBCL R/R*

Lymphoma>NHL>B-Cell>R/R ***

Lymphoma>NHL>B-Cell>SLL>R/R>

Lymphoma>NHL>B-Cell>WM

Lymphoma>NHL>B-Cell>WM>+***

Lymphoma>NHL>T-Cell>ALK+>ALCL

Lymphoma>NHL>T-Cell>CTCL ***

Lymphoma>NHL>T-Cell>CTCL R ***

Lymphoma>NHL>T-Cell>CTCL>CD30+ *

Lymphoma>NHL>T-Cell>CTCL>MF ***

Lymphoma>NHL>T-Cell>CTCL>MF/SS>R/R*

Lymphoma>NHL>T-Cell>Lymphoblastic

Lymphoma>NHL>T-Cell>PTCL ***

Lymphoma>NHL>T-Cell>PTCL R/R *

Lymphoma>NHL>T-Cell>sALCL ***

Lymphoma>NHL>T-Cell>sALCL>R ***

Lymphomatous Meningitis ***

Mastocytosis (PreCancerous) ***

Merkel Cell Carcinoma

Mesothelioma>Pleural>Malignant

MRD & Recurrence Monitoring

MSI Solid Tumors.>Status>DIAG.:

MSI-H Solid Tumors.>MET/R ***

Mucositis>Oral ***

Multiple Myeloma R/R ***

Multiple Myeloma***

Multiple Myeloma>ASCT *

Multiple Myeloma>MRD

Multiple Myeloma>New Diag>ASCT No++

Multiple Myeloma>New Diag>ASCT Yes+

Multiple Myeloma>SRE Prevention***

MyeloDysplastic Syndromes ***

MyeloDysplastic Syndromes>Anemia

MyeloFibrosis ***

Myeloid/Lymphoid Neoplasms with>

MyeloProliferative Neoplasms ***

NanoTechnology ***

NasoPharingeal Carcinoma (NPC)

NET ***

NeuroBlastoma

NeuroFibromatosis Type 1

Oral Cancer ***

Ovarian Cancer ***

Ovarian Cancer Advanced HRD+>

Ovarian Cancer MET BRCA+ ***

Ovarian Cancer MET HRD+

Ovarian Cancer MET Pt-Sensitive ***

Ovarian Cancer MET Pt-Sensitive R**

Ovarian Cancer MET R ***

Ovarian Cancer Pt-Sensitive R ***

Ovarian Cancer R ***

Ovarian Cancer R BRCA+ ***

Ovarian Cancer R HRD+

Ovarian Cancer Stage III or IV>+***

Ovarian Cancer>FRα(+)>PROC

Pain ***

Pancreas Cancer ***

Pancreas Cancer>MET ***

Pancreas Cancer>MET>gBRCAm

Pancreas Cancer>MET>MSI-H***

Partnerships

Perivascular Epithelioid Cell Tumor

PhotoDynamic Therapy ***

Platelet

Polycythaemia Vera

Prostate Cancer Advanced

Prostate Cancer BIOPSY & THERAPY>

Prostate Cancer Diag.

Prostate Cancer mCRPC BRCAm Treat.>

Prostate Cancer mCRPC PSMA+

Prostate Cancer MET ***

Prostate Cancer MET CR ***

Prostate Cancer MET CR BRCA 1/2-Mu>

Prostate Cancer MET CR HR ***

Prostate Cancer MET CS.

Prostate Cancer MET High Risk CS **

Prostate Cancer MET HR ***

Prostate Cancer MET HRR Gene Mutati

Prostate Cancer NON-MET ***

Prostate Cancer NON-MET CR ***

Prostate Cancer Prognostics.

Prostate Cancer R ***

Prostate Cancer Radioactive Diag.

Protein

Radiomics

RadioTherapy (RT)

Robotics. ***

Sarcoma>Epithelioid Sarcoma

Sarcoma>Kaposi s Sarcoma>AIDS***

Sarcoma>OsteoSarcoma>Treat.>***

Sarcoma>Soft Tissue Sarcoma>Locally

Sarcoma>Soft Tissue Sarcoma>MET***

Sarcoma>Synovial Sarcoma MET

Skin Cancer>BCC>Advanced

Skin Cancer>CSCC>MET Or Locally>>

Skin Cancer>DFSP>MET R ***

Skin Cancer>DIAG.

Skin Cancer>Melanoma ***

Skin Cancer>Melanoma>Lymph Node(s)>

Skin Cancer>Melanoma>MET ***

Skin Cancer>Melanoma>MET>BRAF+***

Skin Cancer>Melanoma>MET>NRAS+***

Skin Cancer>Melanoma>UnResectable

Skin Cancer>Merkel Cell C.>MET ***

Skin Cancer>Mohs Surgery>Margin Con

Skin Cancer>Non-Melanoma ***

Software ***

Solid Tumors. ***

Spine Cancer ***

Staging

Testicular Tumor>MET ***

TGCT

ThermoTherapy ***

Thrombocytopenia ***

Thyroid Cancer ***

Thyroid Cancer>Anaplastic>MET>***

Thyroid Cancer>DTC>MET>RAI R

Thyroid Cancer>Medullary>MET ***

Thyroid Cancer>MET>RET Fusion+

Tissue Degeneration

Tumor MicroEnvironment

UK. I. Eye>Uveal Melanoma>Treat.>

UltraSound Therapy ***

Urological>LG UTUC

Urothelial Carcinoma

USA. 1. Technology>aiRNA

USA. D. mUM>Treat.>Melphalan+HDS

Uterus Adenocarcinoma MET ***

VHL CNS Hemangioblastomas

VHL pNET

VHL RCC

VIPoma>Diarrhea ***

ONCOLOGY (**)'s products
This section has no products